Skip to main content
. 2022 May 12;24(7):1370–1379. doi: 10.1111/dom.14714

FIGURE 3.

FIGURE 3

Performance of the MiniMed 780G system over 6 months (cohort 2). The total daily dose of insulin, percentage of time in AHCL and glycaemic outcomes are shown for users aged A, 15 years or younger, and B, Older than 15 years who had 10 or more days of SG data in each of the 6 months following AHCL initiation. AHCL, advanced hybrid closed loop; GMI, glucose management indicator; SG, sensor glucose; TDD, total daily dose